Mark J Rosenblum is Exec VP Finance, CFO of Salarius Pharmaceuticals, Inc.. Currently has a direct ownership of 21,851 shares of SLRX, which is worth approximately $30,591. The most recent transaction as insider was on Feb 13, 2023, when has been sold 6,432 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.9K
0% 3M change
0% 12M change
Total Value Held $30,591

Mark J Rosenblum Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2023
BUY
Grant, award, or other acquisition
-
6,432 Added 22.74%
21,851 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
8,000 Added 34.16%
15,419 Common Stock
Nov 03 2022
BUY
Grant, award, or other acquisition
$12,653 $1.73 p/Share
7,314 Added 4.49%
155,633 Common Stock
May 31 2022
BUY
Open market or private purchase
$5,040 $0.18 p/Share
28,000 Added 15.88%
148,319 Common Stock
May 03 2022
BUY
Grant, award, or other acquisition
$1,900 $0.19 p/Share
10,000 Added 7.67%
120,319 Common Stock
Mar 03 2022
BUY
Open market or private purchase
$29,736 $0.39 p/Share
76,246 Added 40.87%
110,319 Common Stock
Nov 03 2021
BUY
Grant, award, or other acquisition
$5,607 $0.72 p/Share
7,787 Added 18.6%
34,073 Common Stock
May 03 2021
BUY
Grant, award, or other acquisition
$5,451 $0.57 p/Share
9,563 Added 26.68%
26,286 Common Stock
Nov 03 2020
BUY
Grant, award, or other acquisition
$2,645 $0.56 p/Share
4,723 Added 22.02%
16,723 Common Stock
MJR

Mark J Rosenblum

Exec VP Finance, CFO
Houston, TX

Track Institutional and Insider Activities on SLRX

Follow Salarius Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLRX shares.

Notify only if

Insider Trading

Get notified when an Salarius Pharmaceuticals, Inc. insider buys or sells SLRX shares.

Notify only if

News

Receive news related to Salarius Pharmaceuticals, Inc.

Track Activities on SLRX